An announcement was made on February 16th, 2023 by KAIST (President Kwang Hyung Lee) that an advanced AI-based drug interaction prediction technology was developed.
KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.